Cargando…

Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity

Inborn errors of immunity (IEI) are inherited monogenic disorders resulting in defective immune response. Non‐infectious presentations are increasingly more apparent. Widely available, cost‐effective early indicators are needed. Peripheral‐blood cytopenia may be a presenting laboratory feature or an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelissen, Helena M., Musekwa, Ernest M., Glashoff, Richard H., Esser, Monika, Zunza, Moleen, Abraham, Deepthi R., Chapanduka, Zivanai C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544345/
https://www.ncbi.nlm.nih.gov/pubmed/35791731
http://dx.doi.org/10.1111/bjh.18337
_version_ 1784804576782712832
author Cornelissen, Helena M.
Musekwa, Ernest M.
Glashoff, Richard H.
Esser, Monika
Zunza, Moleen
Abraham, Deepthi R.
Chapanduka, Zivanai C.
author_facet Cornelissen, Helena M.
Musekwa, Ernest M.
Glashoff, Richard H.
Esser, Monika
Zunza, Moleen
Abraham, Deepthi R.
Chapanduka, Zivanai C.
author_sort Cornelissen, Helena M.
collection PubMed
description Inborn errors of immunity (IEI) are inherited monogenic disorders resulting in defective immune response. Non‐infectious presentations are increasingly more apparent. Widely available, cost‐effective early indicators are needed. Peripheral‐blood cytopenia may be a presenting laboratory feature or an observed secondary phenomenon. This retrospective review of the South African Primary Immunodeficiency Registry (SAPIDR) aimed to assess the haematological indices at presentation and their association with the International Union of Immunological Societies (IUIS) 2019 IEI classification and mortality. Of 396 patients on the SAPIDR, 66% (n = 257) had available haematological results. Sixty percent were males and 85% under 18 years. A majority (53%) had predominantly antibody deficiency. At presentation, infection was prominent (86%) followed by cytopenia (62%). Neutropenia was associated with IUIS III [odds ratio (OR) 3.65, confidence interval (CI) 1.44–9.25], thrombocytopenia with IUIS II (OR 14.39, CI 2.89–71.57), lymphopenia with IUIS I (OR 12.16, CI 2.75–53.73) and pancytopenia with IUSI I (OR 12.24, CI 3.82–39.05) and IUIS II (OR 5.99, CI 2.80–12.76). Cytopenia showed shorter overall survival (OR 2.81, CI 1.288–4.16). Cytopenias that are severe, persistent, unusual and/or recurrent should prompt further investigation for IEI. The full blood count and leucocyte differential may facilitate earlier identification and serve as an adjunct to definitive molecular classification.
format Online
Article
Text
id pubmed-9544345
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95443452022-10-14 Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity Cornelissen, Helena M. Musekwa, Ernest M. Glashoff, Richard H. Esser, Monika Zunza, Moleen Abraham, Deepthi R. Chapanduka, Zivanai C. Br J Haematol Paediatrics Inborn errors of immunity (IEI) are inherited monogenic disorders resulting in defective immune response. Non‐infectious presentations are increasingly more apparent. Widely available, cost‐effective early indicators are needed. Peripheral‐blood cytopenia may be a presenting laboratory feature or an observed secondary phenomenon. This retrospective review of the South African Primary Immunodeficiency Registry (SAPIDR) aimed to assess the haematological indices at presentation and their association with the International Union of Immunological Societies (IUIS) 2019 IEI classification and mortality. Of 396 patients on the SAPIDR, 66% (n = 257) had available haematological results. Sixty percent were males and 85% under 18 years. A majority (53%) had predominantly antibody deficiency. At presentation, infection was prominent (86%) followed by cytopenia (62%). Neutropenia was associated with IUIS III [odds ratio (OR) 3.65, confidence interval (CI) 1.44–9.25], thrombocytopenia with IUIS II (OR 14.39, CI 2.89–71.57), lymphopenia with IUIS I (OR 12.16, CI 2.75–53.73) and pancytopenia with IUSI I (OR 12.24, CI 3.82–39.05) and IUIS II (OR 5.99, CI 2.80–12.76). Cytopenia showed shorter overall survival (OR 2.81, CI 1.288–4.16). Cytopenias that are severe, persistent, unusual and/or recurrent should prompt further investigation for IEI. The full blood count and leucocyte differential may facilitate earlier identification and serve as an adjunct to definitive molecular classification. John Wiley and Sons Inc. 2022-07-06 2022-09 /pmc/articles/PMC9544345/ /pubmed/35791731 http://dx.doi.org/10.1111/bjh.18337 Text en © 2022 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Paediatrics
Cornelissen, Helena M.
Musekwa, Ernest M.
Glashoff, Richard H.
Esser, Monika
Zunza, Moleen
Abraham, Deepthi R.
Chapanduka, Zivanai C.
Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity
title Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity
title_full Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity
title_fullStr Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity
title_full_unstemmed Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity
title_short Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity
title_sort peripheral‐blood cytopenia, an early indicator of inborn errors of immunity
topic Paediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544345/
https://www.ncbi.nlm.nih.gov/pubmed/35791731
http://dx.doi.org/10.1111/bjh.18337
work_keys_str_mv AT cornelissenhelenam peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity
AT musekwaernestm peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity
AT glashoffrichardh peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity
AT essermonika peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity
AT zunzamoleen peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity
AT abrahamdeepthir peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity
AT chapandukazivanaic peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity